Allied Biotech (ROCO:1780) ROCE %: 21.74% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1780 Allied Biotech Corp ROCO:1780
77 GF Score
Price NT$22.30
GF Value NT$20.77
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Allied Biotech ROCE %?

Allied Biotech ROCO:1780 -1.76% 77 ROCE % is 21.74% as of Dec. 2025. GuruFocus rates ROCO:1780 with a GF Score™ of 77/100 and a GF Value™ of NT$20.77 (Fairly Valued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Allied Biotech's annualized ROCE % for the quarter that ended in Dec. 2025 was 21.74%.

Allied Biotech  (ROCO:1780) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Allied Biotech ROCE % Related Terms

Allied Biotech ROCE % Historical Data

* Premium members only.

The historical data trend for Allied Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allied Biotech ROCE % Chart

Allied Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.42 16.52 10.66 11.47 14.22

Allied Biotech Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.99 24.69 -17.02 28.68 21.74
ROCO:1780
77GF Score
Allied Biotech Corp ROCO:1780
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allied Biotech ROCE % Calculation

Allied Biotech's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=181.444/( ( (2256.855 - 996.249) + (2091.803 - 800.04) )/ 2 )
=181.444/( (1260.606+1291.763)/ 2 )
=181.444/1276.1845
=14.22 %

Allied Biotech's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=274.572/( ( (2297.372 - 1063.731) + (2091.803 - 800.04) )/ 2 )
=274.572/( ( 1233.641 + 1291.763 )/ 2 )
=274.572/1262.702
=21.74 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 21.74% mean?
Allied Biotech (ROCO:1780) has a ROCE % of 21.74% as of Dec. 2025.
Is Allied Biotech's ROCE % too high?
Allied Biotech's current ROCE % is 21.74%. The Drug Manufacturers industry median ROCE % is 7.05. Allied Biotech's value of 21.74% is 208.4% above this industry median. Overall, Allied Biotech has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's ROCE % compare to ZTS and UTHR?
Allied Biotech's ROCE % of 21.74% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.05. Allied Biotech's value of 21.74% is 208.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.05, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allied Biotech's current ROCE % of 21.74% is 208.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allied Biotech's current ROCE % is 21.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.77, compared to a current price of NT$22.30 — trading 7.4% above its estimated fair value. The current ROCE % is 21.74% and 208.4% above the Drug Manufacturers industry median of 7.05. Allied Biotech's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current ROCE % is 21.74% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allied Biotech (ROCO:1780) Overvalued in 2026?

Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued. The current stock price of NT$22.30 is trading 7.4% above its estimated GF Value™ of NT$20.77. GuruFocus considers Allied Biotech to be Fairly Valued.

Key valuation signals for ROCO:1780:

  • ROCE %: 21.74%
  • GF Value™: NT$20.77 vs. price of NT$22.30 (7.4% above fair value)
  • GF Score™: 77/100 with 5 warning signs
  • Industry Position: 208.4% above the Drug Manufacturers median

No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allied Biotech Business Description

Address No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
77GF Score

Get the complete analysis for ROCO:1780

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.30
Price
NT$20.77
GF Value